Prof. B. Jayaram | SCFBio, IIT Delhi
Chem Talks Computer Aided Drug Design
Lab Theme Talks
Latest Updates
- New We are accepting Dissertation Project application for Winter Semester.
- New New publication: Structure and dynamics dictate the functional destiny of genomic DNA across multiple organisms.
- New New publication: BIMP: Unveiling the Phytochemical Richness of Indian Medicinal Plants as Potential Therapeutic Agents.
Manuscript Accepted - New New publication: Prioritizing candidate drugs via virtual screening, docking and simulations.
Manuscript Accepted - SCFBio welcomes new PhD students for the winter semester.
- BIMP database updated.
- New Genomics Software Tool on GitHub!
Our Services
Genomics
Deep learning integrated, physicochemical property-based exon-intron boundary prediction method, ChemEXIN.
Structure Prediction
Reliable protein structure prediction using our in-house BhageerathH+ software suite.
Active Site Prediction
Compute potential active sites and cavities within a given protein structure by AADS.
Virtual Screening
High-throughput screening using our advanced RASPD+ & SEARCH-ML machine learning models.
Molecular Docking
All-atom energy-based Monte Carlo simulations for rigid protein-ligand docking by ParDOCK+.
MD Simulations
Analyzing the physical movements of atoms and molecules for dynamic insights.
Our Journey: A Timeline of Facility
From our inception to becoming a Centre of Excellence, a look at our key milestones.
2002
Founding of SCFBio
Established at IIT Delhi with funding from DBT, DST, and CSIR.
2009
Upgrade to Multi-Teraflop
Facility upgraded with support from DBT to over 6 Teraflops.
2013
Centre of Excellence
Recognized by DBT, Govt. of India.
2018
Liquid-Immersed Cooling
Augmented with a first-of-its-kind system, boosting capacity to 60 Teraflops.
Research Units
Our Story
Founded in 2002, SCFBio aims to revolutionize healthcare via personalized medicine.
Our Mission
To develop novel scientific methods and efficient algorithms combining Chemistry, Biology, and IT.
Our Vision
To pioneer personalized medicine by seamlessly integrating genetic insights with drug development.